General Information

Thank you for your interest in submitting an abstract to the 16th Annual Meeting of the College of Psychiatric and Neurologic Pharmacists (CPNP) to be held April 21 – April 24, 2013, in Colorado Springs, Colorado. Posters will be displayed April 21 and 22, and published on and in the June 2013 issue of the Journal of Pharmacy Practice. The abstract submission is now closed.

Awards are available in five different categories (additional details and eligibility requirements are documented in the 2013 CPNP Poster Presenter Handbook):

  • Research Trainee Award: Qualified abstracts include a Work in Progress and Original Research. Interim data analysis required, and the first author must be a student, resident, fellow, or within 12 months of completion of training.
  • New Investigator Award: Original Research abstracts are eligible, and the first author must be less than 5 years since completion of training.
  • Original Research: Abstracts should describe original research in therapeutics, pharmacodynamics, pharmacoeconomics, outcomes, drug utilization, kinetics and genetics. Abstracts must not have been published in abstract form nor presented as a poster elsewhere before the CPNP 2013 Meeting.
  • Innovative Practices Award: Abstracts describing the development, justification, documentation, and/or delivery of innovative services or activities applicable to psychiatric and neurologic pharmacy. The descriptive abstract should not duplicate any other poster category and should describe the development of innovative services/activities and should provide background/rationale, a description of the innovative service, the impact on patient care/institution and a conclusion.
  • Therapeutic Case Report Award: Abstracts describing the various aspects of pharmaceutical care relating to individual psychiatric and/or neurological pharmacy cases. Abstracts should provide a complete patient history including age, gender, time from first diagnosis, social background, and details of, and response to, previous and current treatment(s). Cases should include background, complete patient history, review of literature, and conclusion.

Award Finalists

Research Trainee Award Finalists

2:00-2:15 p.m.: James Stevenson, PharmD, PGY Pharmacy Practice Resident, University of Illinois at Chicago, Chicago, IL
Serotonin Transporter 5HTTLPR Polymorphism and Neurocognitive Outcomes in Lithium-Treated Pediatric and Adolescent Bipolar Disorder

2:15-2:30 p.m.: Katy Zeier, PharmD, PGY2 Psychiatric Pharmacy Resident, Chillicothe Veterans Affairs Medical Center, Chillicothe, OH
A Retrospective Chart Review of a Symptom-Triggered Alcohol Withdrawal Protocol Versus Previous Standard of Care at a Veteran's Hospital

Innovative Practices Award Finalists

2:30-2:45 p.m.: Bethany DiPaula, PharmD, BCPP, Associate Professor, Director of Pharmacy, University of Maryland, Sykesville, MD
Pharmacist-Physician Collaborative Care Model for Suboxone-Maintained Patients at a Health Department

2:45-3:00 p.m.: Kelly Williams, PharmD, BCPP, Clinical Pharmacy Specialist, Outpatient Psychiatry, Wishard Health Services/Midtown Community Mental Health Center, Indianapolis, IN
Pharmacist-Managed Olanzapine Long-Acting Injection Clinic in A Community Mental Health Center

Therapeutic Case Report Award Finalists

3:15-3:30 p.m.: Jessica Brennan, PharmD, Psychiatric Clinical Pharmacist, Western Psychiatric Institute and Clinic/University of Pittsburgh Medical Center, Pittsburgh, PA
Reversal of Korsakoff's Syndrome Following High Dose Intramuscular Thiamine

3:30-3:45 p.m.: Clinton Ross, PharmD, Psychiatric Clinical Pharmacist, Western Psychiatric Institute and Clinic/University of Pittsburgh Medical Center, Pittsburgh, PA
High Dose Haloperidol Decanoate Augmentation with Paliperidone Palmitate

New Investigator Award Finalist

3:45-4:00 p.m.: Michael Kemp, PharmD, BCPP, Psychiatric Pharmacist, Vitality Health Authority, Moncton, NB
Impact of a Theophylline Loading Dose on Seizure Quality Indices During Electroconvulsive Therapy: A Retrospective Study

Original Research Award Finalists

4:00-4:15 p.m.: Jack Chen, PharmD, BCPS, CGP, FASCP, FCCP, Associate Professor, Loma Linda University, Loma Linda, CA
ANCHOR-CD: The Abobotulinumtoxin-A Neurotoxin Clinical & Health Economics Outcomes Registry in Cervical Dystonia

4:15-4:30 p.m.: Lisa Goldstone, PharmD, MS, BCPS, Assistant Professor, University of Arizona College of Pharmacy, Tucson, AZ
Economic Impact of Public Benefit Changes on Seriously Mentally Ill Patients in Southern Arizona